Recent reports suggest that, contrary to radioimmunoassays (RIA) 
The etiologies of Cushing's syndrome can be classified as ACTH-dependent causes which include Cushing's dis¬ ease and the ectopic ACTH syndrome, and as ACTHindependent causes such as primary adrenocortical diseases ( 1 ) . The distinction between these two entities is the first step of the etiological investigation of Cushing's syndrome. It is usually resolved with plasma ACTH measurement (2) . The poor sensitivity of most of the commercially available radioimmunoassays for ACTH (ACTH-RIA) do not provide reliable discrimination between ACTH-dependent and independent entities. However, the sensitivity of the assay has recently been improved by the development of two-sites immunoradiometric assays (ACTH-IRMA) (3, 4) . On the contrary, it still remains difficult to distinguish between Cushing's disease and the ectopic ACTH syndrome (1, 5) . In this etiological investigation, plasma ACTH levels are poorly discriminative (5) but the presence of ACTH fragments (6) (7) (8) or large molecular forms ("Big" ACTH) is highly suggestive of the ectopic ACTH syndrome (7, (9) (10) (11) .
Demonstration of such abnormalities requires Chroma¬ tographie characterization of ACTH immunoreactivity, which is time-consuming, or the use of specific assays for ACTH precursors which are not commercially available (12) . The (4) .
Elsewhere, the measurement of other proopio-melanocortin end-product peptides such as /?-lipotropin (/Î-LPH), has proven to be useful for the differential diagnosis between Cushing's disease and ectopic ACTH syndrome (13) (14) . Few (rs = 0.59; p<0.02) (Fig. 1A) . (Fig. 2B) . The /5-endorphin/ACTH-RIA and ß-endorphin/ACTH-IRMA molar ratio were higher than in patients with Cushing's disease.
Individual results (Fig. 3) Since overall results suggested that the determination of ACTH-RIA and /?-endorphin concentrations, and that the calculation of ACTH-RIA/ACTH-IRMA and ß-endorphin/ACTH-IRMA molar ratio, could be useful for the distinction between Cushing's disease and the ectopic (3, 4) .
The specificity of the IRMA may be its only limitation since only ACTH 1-39 forms a "sandwich" complex with the N-and the C-terminal antibodies of the assay.
Larger molecular weight precursors or ACTH fragments are not measured and artifactually decrease the ACTH-IRMA concentration (4, 24) . These variants are prefer¬ entially secreted by ectopic tumours (6) (7) (8) (9) (10) (11) and their detection in the plasma may aid in differentiating Cushing's disease from the ectopic ACTH syndrome ( 5, 12 ). An indirect but easy way to detect these could be the concomitant use of an ACTH-IRMA with a less specific assay, such as a RIA, which does measure some of these ACTH variants (4) . As expected, the ACTH-IRMA values in the ectopic ACTH syndrome and Cushing's disease patients of our study were similar but the ACTH-RIA concentration was significantly higher in the ectopic ACTH (24, 26, 27 
